OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy
S. D. Singh, Navneet Singh, Manoj Baranwal, et al.
3 Biotech (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 5
S. D. Singh, Navneet Singh, Manoj Baranwal, et al.
3 Biotech (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 5
Showing 5 citing articles:
Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape
S. S. Kirthiga Devi, S. D. Singh, Ramesh Joga, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114323-114323
Closed Access | Times Cited: 10
S. S. Kirthiga Devi, S. D. Singh, Ramesh Joga, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114323-114323
Closed Access | Times Cited: 10
Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa
Min‐Jae Kim, Yeonjin Je, Jaeyoung Chun, et al.
Helicobacter (2025) Vol. 30, Iss. 2
Open Access
Min‐Jae Kim, Yeonjin Je, Jaeyoung Chun, et al.
Helicobacter (2025) Vol. 30, Iss. 2
Open Access
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 3
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 3
Druggability properties of a L309K mutation in the antibody CH2 domain
Cui Li, Qingqing Yao, Jiang Li
3 Biotech (2024) Vol. 14, Iss. 6
Closed Access
Cui Li, Qingqing Yao, Jiang Li
3 Biotech (2024) Vol. 14, Iss. 6
Closed Access
Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer
Jin Shi, Xudong Song, Zihao Gao, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38710-e38710
Open Access
Jin Shi, Xudong Song, Zihao Gao, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38710-e38710
Open Access
